• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Don't Be in a Rush to Invest in Cisco

Someone already long this stock, who has taken a hit, doesn't need to liquidate unless...
By STEPHEN GUILFOYLE
May 19, 2022 | 11:00 AM EDT
Stocks quotes in this article: CSCO

Cisco (CSCO) reported last night. Cisco sold-off last night. My knee-jerk reaction? They didn't get me this time. As a trader/ investor who has always had a high opinion of CEO Chuck Robbins and was always willing to give a reasonably valued tech stock like Cisco that pays a nice dividend a fair chance... "they" had gotten me a few times in the past.

This time it may be different. We have heard that many times before. This time, the firm actually took guidance down a peg or two. Maybe this time... is "the" time. Let's check these numbers out.

For the period ending April 30th, which happens to be Cisco's fiscal third quarter, the firm posted adjusted EPS of $0.87 (GAAP: $0.73) on revenue of $12.84B. The top line number fell short of Wall Street's expectations, and was barely good enough for any year over year growth (+0.3%) at all. The adjusted bottom line result represented 5% annual growth and did beat Wall Street by a penny.

The firm points out very early in the press release that progress has been made on it's business model transformation with total Annualized Recurring Revenue (ARR) running at $22.4B, up 11% from the comparable quarter last year.

The CEO

Chuck Robbins, chair and CEO of Cisco, reassured investors with commentary made in that release... "We continued to see solid demand for our technologies and our business transformation is progressing well. While Covid lockdowns in China and the war in Ukraine impacted our revenue in the quarter, the fundamental drivers across our business are strong and we remain confident in the long term."

How Significant Were Those Impacts?

Cisco announced in March that the firm would halt business operations in both Russia and Belarus. Total negative revenue impact from this disruption came to an estimated $200M. Historically, Russia, Belarus, and Ukraine combined contribute about 1% to Cisco's total revenue. This impact is greater than that to account for costs associated with ending the business there. These numbers are in the press release.

During the conference call, Robbins mentioned that the firm suffered an estimated $300M negative revenue impact completely attributed to the firm's inability to get power supplies out of China during lockdowns. That's an aggregate negative impact of $500M. Exactly how much the firm's actual revenue number fell short of consensus for the quarter.

Business Line Performance

The firm reports results for two business lines... Products and Services. The Products line is then further broken down into five units.

Secure Agile Networks: sales increased 4% to $5.869B.

Internet for the Future: sales increased 6% to $1.324B.

Collaboration: sales decreased 7% to $1.132B.

End to End Security: sales increased 7% to $938M.

Optimized Application Experiences: sales increased 8% to $183M.

Products (totaled): sales increased 3% to $9.448B.

Services: sales decreased 8% to $3.387B.

Almost a Bright Spot

While revenues in aggregate disappointed, to be fair.. both adjusted EPS and revenue printed in line with what Cisco has produced for each of the prior four quarters. It's just that more was expected. There was however, a bright spot, or almost a bright spot...and that spot was margin.

Adjusted total gross margin came to 65.3%, which was down from 66% one year ago, but well above consensus view for little more than 64%. Adjusted product gross margin printed at 64.1%, while adjusted Services gross margin landed at 68.9%. This leads to adjusted operating margin of 34.7%, which was also well above the prevailing consensus view.

Guidance

Here's where it gets ugly.

For the current quarter: Cisco sees revenue contracting anywhere from -1% to -5.5%, and adjusted EPS printing at $0.76 to $0.84. Wall Street had been at $0.92.

For the full year (three quarters in):  Cisco sees revenue growing 2% to 3%, resulting in Adjusted EPS of $3.29 to $3.37. Wall Street was looking for $3.44.

Balance Sheet

As of April 30th, Cisco has a net cash position of $20,108B and inventories worth $2.231B on the books. This brought current assets down to $35.981B. Current liabilities add up to $24.15B, leaving the firm with a current ratio of 1.49 (healthy), and a quick ratio of 1.39 (also healthy).

Total assets amount to $92.797B, but that does include $38.452B in "goodwill" and another $2.811 worth of "purchased intangible assets." Hmm. I get the concept of what intangible assets are. Adding the word "purchased" implies that you paid something for it, but it's not really quantifiable. Super. Anyway, that's $41.263B worth of assets that can not be counted or seen on the balance sheet, or 44.5% of all assets. Again.. super.

Total liabilities less equity add up to $52.397B, including $8.418B in long-term debt. (The firm also has $1B in short-term debt that counts towards the current and quick ratios.) I have no real problem with Cisco's balance sheet. It passes the Sarge test. The firm can pay off their debt-load out of pocket if they had to. That's a lot of "goodwill" but that does not negatively impact my overall perception of Cisco's books.

My Thoughts

The firm has warned you that its problems... issues with the supply chain in China and the war in Ukraine are not easily rectifiable. They have guided the current quarter and the full year (really two quarters) below consensus. There is no reason to rush your decision on this. CSCO is not really a trader, but it could be an investment for a revenue seeking individual.

Cisco pays shareholders $1.52 per year per share. This morning, that's a yield of about 3.6%. The firm is also buying back shares as well. Cisco repurchased $252M worth of shares during the quarter reported. The firm has $17.6B left on its current authorization, and will now have a cheaper stock to buy.

The model I use for these articles for some reason only has the 38.2%and 61.8% Fibonacci retracement levels on its model. (50% is not really a Fib level) Therefore, I placed the 23.6% and 78.6% retracement levels on this chart for you. Readers will find that CSCO has found at least temporary support above the stock's 78.6% Fib retracement of the entire November 2020 through December 2021 rally.

My opinion would be that someone already long this stock, who has already taken this hit, does not need to liquidate unless that spot, which is $39.20 should fail. In fact, should CSCO approach that price, I think I may dip my toes into the sea. If interested, the June 10th $39 puts are paying about $0.60 this morning.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Stephen Guilfoyle had no position in the securities mentioned.

TAGS: Earnings | Economy | Investing | Stocks | Technical Analysis | Trading | Technology

More from Investing

The Charts Point to More Selling Ahead for 4 Former Tech Leaders

Ed Ponsi
Jul 1, 2022 10:00 AM EDT

Keep in mind that no matter how much a stock has fallen, it can always go lower, and it appears these four stocks could prove that point.

Enanta Pharmaceuticals Bounces Off a Key Support Level Once Again

Bruce Kamich
Jul 1, 2022 9:41 AM EDT

The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich
Jul 1, 2022 8:43 AM EDT

Here's our current price target.

A Few Thoughts on How to Approach a Tougher Bear Market Than Most

Bob Byrne
Jul 1, 2022 8:30 AM EDT

A key goal is to keep from losing money while the current bear runs its course, and don't count on positive seasonality leading to the Fourth of July.

Four Things I Know for Sure About the Market

James "Rev Shark" DePorre
Jul 1, 2022 8:06 AM EDT

As the second half of 2022 begins, keep this quarter of observations in mind.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login